Baker Avenue Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-400
| Closed | -$3.01K | – | 1711 |
|
|
2023
Q2 | $3.01K | Buy |
400
+366
| +1,076% | +$2.76K | ﹤0.01% | 909 |
|
|
2023
Q1 | $301 | Buy |
+34
| New | +$301 | ﹤0.01% | 1556 |
|
|
2019
Q2 | – | Sell |
-47,322
| Closed | -$742K | – | 248 |
|
|
2019
Q1 | $742K | Buy |
+47,322
| New | +$742K | 0.06% | 154 |
|
|
2017
Q3 | – | Sell |
-25,655
| Closed | -$852K | – | 226 |
|
|
2017
Q2 | $852K | Buy |
+25,655
| New | +$852K | 0.11% | 121 |
|